PAVmed Inc. Files Material Definitive Agreement 8-K

Ticker: PAVM · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1624326

Sentiment: neutral

Topics: material-agreement, filing, corporate-news

TL;DR

PAVmed Inc. signed a big deal, filing an 8-K today.

AI Summary

On June 23, 2025, PAVmed Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits. The company, formerly known as PAXmed Inc., is incorporated in Delaware and headquartered in New York.

Why It Matters

This filing indicates a significant new contract or partnership for PAVmed Inc., which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial filing.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by PAVmed Inc.?

The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 23, 2025.

What was PAVmed Inc.'s former company name?

PAVmed Inc.'s former company name was PAXmed Inc.

In which state is PAVmed Inc. incorporated?

PAVmed Inc. is incorporated in Delaware.

What is the principal executive office address for PAVmed Inc.?

The principal executive office address for PAVmed Inc. is 360 Madison Avenue, 25th Floor, New York, New York 10017.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding PAVmed Inc. (PAVM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing